United Statesaquilopartners.com
Aquilo Partners, L.P. is an independent U.S.-based investment bank and financial advisory firm focused on the life sciences sector, with an emphasis on biotechnology and biopharmaceutical companies.
The firm advises public and private clients on mergers and acquisitions, strategic alternatives, licensing and partnering transactions, and capital raising, including private placements. Its work spans companies at discovery, clinical, and commercial stages, providing transaction execution and board-level advisory services relevant to the biopharma and healthcare ecosystem.
None yet. When a new project in the record names Aquilo Partners as owner, partner or investor, it shows here.
Lilly's tender offer for Adverum shares expired, with 64% tendered. Acquisition completion expected Dec. 9, 2025. Legal and financial advisors involved.
